Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nirogacestat CYP Induction Study in Healthy Males
NCT07259330Phase 1Completed
- Sponsor
- SpringWorks Therapeutics
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of nirogacestat (2 arms), sponsored by SpringWorks Therapeutics. Primary endpoints: Area Under the Curve Extrapolated to Infinity at Day 15 and Maximum Observed Plasma Concentration at Day 15. Started Oct 2025; status: completed.
02
Drugs
nirogacestat
Beyond the preview
Go deeper on NCT07259330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07259330.